Ryan Allway October 4th, 2021 Expands Colorado Outdoor Cultivation Capacity with 66 acres in 2nd Largest U.S. Cannabis Market Acquisition Completes Curaleaf’s Vertical Integration and Bolsters State’s Biomass Production WAKEFIELD, Mass., Oct. 4, 2021 /CNW/ — Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer products in... Read more
Matica Subsidiary West Island Introduces New Brand to the B.C. Non-Medical Cannabis Market
Ryan Allway August 19th, 2021 Toronto, Ontario–(Newsfile Corp. – August 18, 2021) – Matica Enterprises Inc. (CSE: MMJ) (FSE: 39N) (OTCQB: MMJFF) (“Matica” or the “Company”) is pleased to announce that the Company’s subsidiary, RoyalMax Biotechnology Canada Inc. doing business as West Island Culture (“West Island”) is launching the CITOYEN™ brand... Read more
Silo Pharma Takes Next Step in Bringing Homing Peptide Tech to $30+ Billion RA Market
Ryan Allway July 23rd, 2021 Psychedelics, Top Story, Uncategorized Rheumatoid arthritis, or RA, is an autoimmune and inflammatory disease that causes painful swelling in joints in the hands, wrists, and knees. While medications can slow the disease and prevent joint deformity, there is no cure for the condition, and... Read more
Decibel Appoints Paul Wilson as CEO
Ryan Allway June 22nd, 2021 News, Top News CALGARY, AB, June 22, 2021 /PRNewswire/ – Decibel Cannabis Company Inc. (the “Company” or “Decibel”) (TSXV: DB) (OTCQB: DBCCF), a premium cannabis producer, is pleased to announce  the appointment of Paul Wilson as its Chief Executive Officer, effective Wednesday, June 23rd. Emphasizing the Company’s objective for brand... Read more
Dispensaries Can Boost Cannabis Sales with Unique Topical Products
Robin Lefferts June 7th, 2021 App, Exclusive, News, Top Story As the legal cannabis industry matures and expands, the goal of many companies is (and should be) to reach people who might not historically be cannabis consumers. According to a 2020 Gallup poll, about 12% of US adults say... Read more
Revive Takes a Step Closer to Launching New Psychedelic Delivery Mechanism
Ryan Allway April 30th, 2021 Psychedelics, Top News Mental illness is the leading cause of disability in developed countries. In fact, half of Americans will experience mental illness in their lifetime and $350 billion is spent each year on treating depression in the U.S. and Europe alone. Psychedelics have... Read more
Psychedelics Then & Now: From Ancient Times to the Psychedelic Renaissance
Ryan Allway April 14th, 2021 App, Exclusive, Psychedelics, Top Story Psychedelics have become one of the most promising classes of drugs in a generation, as well as an exciting new industry for investors. Despite their resurgence among researchers and investors, psychedelics have been used for thousands of years before... Read more
Looking For How To Invest In Cannabis Stocks For The Long Term? 2 With Potential In 2021
MagicMed wendet die Idee des Modells einer Bibliothek für Medikamentenkandidaten auch auf Psychedelika an
Ryan Allway January 20th, 2021 German, Psychedelics Der Psychedelika-Markt wird oft mit Wörtern, wie “aufstrebend”, “aufkeimend” und ähnlichen beschrieben, und obwohl dies sicherlich weitgehend zutrifft, sollten Anleger keinen Moment denken, dass dies alles neu ist. Das Gegenteil ist der Fall. Es gibt eine Vielzahl klinischer und präklinischer Daten, die... Read more
Innovation zahlt sich aus bei Psychedelika
Es besteht ein erhebliches Interesse am psychedelischen Bereich und an den vielversprechenden psychedelischen Molekülen für die Behandlung von psychischen Erkrankungen. Geisteskrankheiten sind eine allgegenwärtige menschliche Erfahrung und eine bisher nur unzureichend behandelte medizinische Notwendigkeit. Psychedelika bieten eine Alternative zu unwirksamen Behandlungen, da sie über andere Wirkmechanismen funktionieren. Psychedelische Arzneimittel... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )